AUDENTES THERAPEUTICS INC's ticker is BOLD and the CUSIP is 05070R104. A total of 117 filers reported holding AUDENTES THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is 0.70 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $32,126,000 | +47.9% | 536,873 | -30.6% | 0.04% | +17.6% |
| Q3 2019 | $21,721,000 | +10.7% | 773,279 | +49.2% | 0.03% | +17.2% |
| Q2 2019 | $19,619,000 | -29.3% | 518,193 | -27.1% | 0.03% | -31.0% |
| Q1 2019 | $27,736,000 | +120.1% | 710,809 | +20.3% | 0.04% | +110.0% |
| Q4 2018 | $12,600,000 | -2.2% | 590,974 | +75.3% | 0.02% | +17.6% |
| Q2 2018 | $12,879,000 | +102.8% | 337,055 | +59.5% | 0.02% | +112.5% |
| Q1 2018 | $6,351,000 | +87.0% | 211,348 | +74.3% | 0.01% | +60.0% |
| Q3 2017 | $3,397,000 | -2.1% | 121,275 | -33.1% | 0.01% | -16.7% |
| Q2 2017 | $3,470,000 | +135.6% | 181,370 | +109.8% | 0.01% | +100.0% |
| Q1 2017 | $1,473,000 | -8.1% | 86,437 | -1.5% | 0.00% | 0.0% |
| Q4 2016 | $1,603,000 | – | 87,755 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 1,204,615 | $36,198,681,000 | 11.58% |
| Sofinnova Investments, Inc. | 1,380,303 | $41,478,000 | 7.13% |
| Casdin Capital, LLC | 450,000 | $13,523,000 | 2.38% |
| Foresite Capital Management III, LLC | 315,331 | $9,476,000 | 2.06% |
| Opaleye Management Inc. | 190,000 | $5,709,000 | 1.63% |
| Redmile Group, LLC | 1,308,526 | $39,321,000 | 1.52% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,384,470 | $41,603,000 | 1.44% |
| Orbimed Advisors | 3,522,100 | $105,839,000 | 1.31% |
| Rock Springs Capital Management LP | 565,000 | $16,978,000 | 0.72% |
| Cormorant Asset Management, LP | 322,945 | $9,704,000 | 0.72% |